Although PSA is used as a tumor marker and screening parameter, it is not tumor- but only prostate-specific [12] and, apart from intraindividual variations, can rise in the context of several circumstances other than PCa, such as benign prostatic hyperplasia, prostatitis or other manipulations of the prostate [12,13]. The gene discussed is KLK3; the disease is neoplasm.